Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION ( Stock Option Activity) (Details)

v3.22.0.1
STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Legacy Plan    
Number of options    
Granted (in shares) 0  
Employees | Legacy Plan    
Number of options    
Outstanding at the beginning of the period (in shares) 12,185,210  
Consultant has become employee (in shares) (628,509)  
Granted (in shares) 1,590,997  
Forfeited (in shares) (257,574)  
Expired (in shares) (51,018)  
Exercised (in shares) (2,973,476)  
Outstanding at the end of the period (in shares) 11,122,648 12,185,210
Exercisable options at the end of the period (in shares) 7,139,268  
Weighted average exercise price    
Outstanding at the beginning of the period (in USD per share) $ 0.37  
Consultant has become employee (in USD per share) 0.61  
Granted (in USD per share) 2.81  
Forfeited (in USD per share) 0.91  
Expired (in USD per share) 0.59  
Exercised (in USD per share) 0.50  
Outstanding at the end of the period (in USD per share) 0.82 $ 0.37
Exercisable exercise price at the end of the period (in USD per share) $ 0.51  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 6 years 10 months 13 days 7 years 2 months 12 days
Outstanding exercisable, weighted average remaining contractual term (in years) 5 years 8 months 23 days  
Outstanding intrinsic value at the beginning of the period $ 3,100  
Outstanding intrinsic value at the end of the period 64,818 $ 3,100
Outstanding exercisable intrinsic value at the end of the period $ 43,862  
Consultants | Stock Option Plan    
Number of options    
Outstanding at the beginning of the period (in shares) 1,019,318  
Consultant has become employee (in shares) (628,509)  
Granted (in shares) 99,628  
Forfeited (in shares) (27,581)  
Expired (in shares) 0  
Exercised (in shares) (283,229)  
Outstanding at the end of the period (in shares) 179,627 1,019,318
Exercisable options at the end of the period (in shares) 123,515  
Weighted average exercise price    
Outstanding at the beginning of the period (in USD per share) $ 0.51  
Consultant has become employee (in USD per share) 0.61  
Granted (in USD per share) 2.81  
Forfeited (in USD per share) 0.61  
Expired (in USD per share) 0  
Exercised (in USD per share) 1.22  
Outstanding at the end of the period (in USD per share) 0.31 $ 0.51
Exercisable exercise price at the end of the period (in USD per share) $ 0.35  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 2 years 4 months 2 days 6 years 3 months 25 days
Outstanding exercisable, weighted average remaining contractual term (in years) 2 years 3 months 29 days  
Outstanding intrinsic value at the beginning of the period $ 213  
Outstanding intrinsic value at the end of the period 1,139 $ 213
Outstanding exercisable intrinsic value at the end of the period $ 778